NCT06103201PHASE1RecruitingAccepts Healthy Volunteers

Hyperpolarized 13C-pyruvate Metabolic MRI With Traumatic Brain Injury

University of Maryland, Baltimore

Start Date

10/26/2023

Completion Date

11/26/2027

Summary

The purpose of this study is to examine the safety and feasibility of using hyperpolarized metabolic MRI to study early brain metabolism changes in subjects presenting with head injury and suspected non-penetrating traumatic brain injury (TBI). This study will also compare HP pyruvate MRI-derived metrics in TBI patients with healthy subjects as well as Subarachnoid hemorrhage (SAH) patients to better understand if metabolic Magnetic resonance imaging scan (MRI) can improve our ability to diagnose a TBI. The FDA is allowing the use of hyperpolarized \[1-13C\] pyruvate (HP 13C-pyruvate) in this study. Up to 15 patients (5 with TBI, 5 with SAH, and 5 healthy volunteers) may take part in this study at the University of Maryland, Baltimore (UMB).

Eligibility Criteria

Age Range: 18 years to 80 years

Inclusion Criteria: * History of acute head injury with or suspected non-penetrating acute TBI * Suitable to undergo contrast-enhanced MRI * Negative serum pregnancy test Exclusion Criteria: * Inability to undergo MRI scan * Inability to receive IV MRI contrast agents secondary to severe reaction or renal insufficiency * Positive pregnancy test

Interventions

DRUG

Hyperpolarized 13C-Pyruvate

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Traumatic Brain InjurySubarachnoid Hemorrhage

Locations

University of Maryland Baltimore

Baltimore, Maryland 21201

United States